13F reference period
Q3 2026
CUSIP: N62509109
13F reference period
Q3 2026
Institutions Reporting
138
Shares (Excl. Options)
Price
$24.32
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 138 institutions filings for Q3 2026.
Security key
N62509109
13F reference period
Q3 2026
13F holders
138
13D/G owners
8
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP N62509109:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $262,454,757 | +$24,597,570 | 12,207,198 | +10% | RA Capital Management, L.P. | 30 Sep 2026 |
| Capital World Investors | 10% | +19% | $460,111,232 | +$89,303,892 | 12,188,377 | +24% | Capital World Investors | 29 May 2026 |
| FMR LLC | 10% | +13% | $265,943,062 | +$35,678,767 | 11,941,763 | +15% | FMR LLC | 30 Sep 2026 |
| Frazier Life Sciences X, L.P. | 8.7% | +12% | $269,987,402 | +$46,627,382 | 10,424,224 | +21% | Frazier Life Sciences Public Fund, L.P. | 18 Sep 2026 |
| Forbion Capital Fund IV Cooperatief U.A. | 8.3% | -12% | $223,140,090 | -$30,222,313 | 9,316,914 | -12% | ForGrowth NAP B.V. | 26 Sep 2025 |
| Janus Henderson Group Ltd. | 7.5% | $199,813,010 | 8,972,295 | JANUS HENDERSON GROUP Ltd. | 30 Sep 2026 | |||
| VIKING GLOBAL INVESTORS LP | 3.7% | -40% | $144,476,598 | -$95,375,616 | 4,203,567 | -40% | VIKING GLOBAL INVESTORS LP | 31 Dec 2025 |
| BCLS II Investco, LP | 1.8% | -59% | $74,671,230 | -$120,221,675 | 2,059,896 | -62% | BCLS Fund III Investments, LP | 12 May 2026 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 15% | 18,988,902 | 11% | $461,810,097 | |
| Capital World Investors | 10% | 12,881,484 | 0.04% | $313,277,691 | |
| RA CAPITAL MANAGEMENT, L.P. | 7.7% | 9,550,191 | 2.3% | $232,260,645 | |
| Janus Henderson Group Ltd. | 7.3% | 8,972,293 | 0.09% | $218,258,187 | |
| FCPM III SERVICES B.V. | 6.9% | 8,490,353 | 19% | $206,485,385 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.5% | 4,254,314 | 1.6% | $103,464,916 | |
| Bain Capital Life Sciences Investors, LLC | 3.1% | 3,806,559 | 6.2% | $92,575,514 | |
| Orbis Allan Gray Ltd | 3.1% | 3,760,821 | 0.3% | $91,463,166 | |
| Duquesne Family Office LLC | 2.7% | 3,357,146 | 2% | $81,646,000 | |
| VIKING GLOBAL INVESTORS LP | 2% | 2,463,911 | 0.18% | $59,922,316 | |
| Medicxi Ventures Management (Jersey) Ltd | 1.8% | 2,182,339 | 42% | $53,074,484 | |
| GOLDMAN SACHS GROUP INC | 1.6% | 1,984,732 | 0.01% | $48,268,682 | |
| MAVERICK CAPITAL LTD | 1.5% | 1,855,630 | 0.36% | $45,128,922 | |
| Capital International Investors | 1.5% | 1,842,170 | 0.01% | $44,801,574 | |
| ALLIANCEBERNSTEIN L.P. | 1.2% | 1,440,944 | 0.01% | $35,043,758 | |
| Aberdeen Group plc | 0.96% | 1,184,091 | 0.04% | $28,797,093 | |
| TWO SIGMA INVESTMENTS, LP | 0.92% | 1,135,081 | 0.02% | $27,605,170 | |
| Castle Hook Partners LP | 0.71% | 873,367 | 0.17% | $21,240,285 | |
| Polar Capital Holdings Plc | 0.7% | 866,109 | 0.06% | $21,063,771 | |
| Woodline Partners LP | 0.61% | 752,689 | 0.06% | $18,305,396 | |
| First Turn Management, LLC | 0.57% | 702,396 | 2.3% | $17,082,271 | |
| NWI MANAGEMENT LP | 0.57% | 702,000 | 0.96% | $17,072,640 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.57% | 700,000 | 0.02% | $17,024,000 | |
| Rock Springs Capital Management LP | 0.5% | 613,942 | 0.8% | $14,931,069 | |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.44% | 547,629 | 0.25% | $13,318,337 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 106,381,199 | $2,584,170,683 | +$120,926,876 | $24.32 | 138 |
| 2026 Q2 | 121,990,566 | $4,131,839,683 | -$68,037,466 | $33.89 | 194 |
| 2026 Q1 | 123,556,581 | $3,956,276,151 | +$129,847,431 | $32.01 | 170 |
| 2025 Q4 | 119,332,967 | $4,186,690,487 | -$35,445,065 | $35.08 | 188 |
| 2025 Q3 | 120,390,588 | $3,423,902,136 | +$122,882,388 | $28.44 | 135 |
| 2025 Q2 | 116,368,291 | $2,107,516,504 | +$92,203,105 | $18.11 | 130 |
| 2025 Q1 | 111,177,846 | $2,278,669,708 | +$247,823,372 | $20.47 | 126 |
| 2024 Q4 | 98,611,632 | $2,534,320,573 | +$569,548,998 | $25.70 | 130 |
| 2024 Q3 | 77,090,356 | $1,279,730,929 | +$65,939,934 | $16.60 | 100 |
| 2024 Q2 | 72,010,250 | $1,383,367,935 | -$7,907,090 | $19.21 | 90 |
| 2024 Q1 | 72,152,341 | $1,706,357,479 | +$242,490,357 | $23.65 | 76 |
| 2023 Q4 | 61,897,680 | $691,396,295 | -$81,202 | $11.17 | 32 |
| 2023 Q3 | 50,178,896 | $464,099,871 | +$5,440,463 | $9.25 | 35 |
| 2023 Q2 | 48,833,993 | $580,635,231 | +$184,129,037 | $11.89 | 29 |
| 2023 Q1 | 33,346,896 | $444,858,187 | +$689,119 | $13.26 | 19 |
| 2022 Q4 | 33,516,836 | $362,234,361 | +$362,234,361 | $10.90 | 14 |